Enhancement/NN
of/IN
human/JJ
immunodeficiency/NN
virus/NN
1/CD
replication/NN
in/IN
monocytes/NNS
by/IN
1,25-dihydroxycholecalciferol/NN
./.

Human/JJ
immunodeficiency/NN
virus/NN
(/(
HIV/NN
)/)
expression/NN
and/CC
replication/NN
are/VBP
under/IN
tight/JJ
regulatory/JJ
control/NN
./.
=====
We/PRP
demonstrate/VBP
that/IN
1,25-dihydroxycholecalciferol/NN
[/(
1,25-(OH)2D3/NN
]/)
enhances/VBZ
the/DT
replication/NN
of/IN
monocyte-/NN
and/CC
lymphocyte-tropic/JJ
strains/NNS
of/IN
HIV-1/NN
up/IN
to/TO
10,000-fold/RB
in/IN
monocyte/NN
cell/NN
lines/NNS
,/,
peripheral/JJ
blood/NN
monocytes/NNS
,/,
and/CC
unfractionated/JJ
peripheral/JJ
blood/NN
mononuclear/JJ
cells/NNS
./.
=====
1,25(OH)2D3/NN
is/VBZ
therefore/RB
one/CD
of/IN
the/DT
most/RBS
potent/JJ
regulators/NNS
of/IN
HIV-1/NN
replication/NN
described/VBN
to/TO
date/NN
./.
=====
Precursors/NNS
of/IN
1,25(OH)2D3/NN
enhance/VBP
HIV-1/NN
replication/NN
in/IN
proportion/NN
to/TO
their/PRP$
affinity/NN
for/IN
the/DT
1,25(OH)2D3/NN
intracellular/JJ
receptor/NN
,/,
suggesting/VBG
that/IN
1,25(OH)2D3/NN
influences/VBZ
HIV-1/NN
replication/NN
by/IN
mechanisms/NNS
involving/VBG
this/DT
receptor/NN
./.
=====
These/DT
studies/NNS
may/MD
have/VB
important/JJ
implications/NNS
for/IN
the/DT
design/NN
of/IN
effective/JJ
therapy/NN
of/IN
HIV-1/NN
infection/NN
./.